This conference aims to reignite interest in determining the etiology of ICL, understanding the immunologic mechanisms that distinguish ICL from the CD4 Lymphocytopenia seen in other conditions such as HIV/AIDS or chemotherapy, and investigating potential treatments for ICL.
